Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 3 (RPL12P3)

Target: RPL12P3
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L12 pseudogene 3 (RPL12P3) is a processed pseudogene in the human genome. Pseudogenes such as RPL12P3 result from duplication or retrotransposition events involving the parent gene, in this case ribosomal protein L12 (RPL12). However, unlike the original protein-coding gene, RPL12P3 is generally considered nonfunctional, does not contribute to ribosome assembly or protein synthesis, and is not expressed as a functional protein product. There are no known therapeutic roles, disease associations, or direct drug interactions for this pseudogene.

Other names: bA49G10.7RPL12_17_1694RPL12P3

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 3 (RPL12P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 3 (RPL12P3).

Explore the full profile